Indication
Reduce LDL-cholesterol, apolipoprotein B & triglycerides. Increase HDL-cholesterol in the treatment of hyperlipidemia including hypercholesterolemia & combined (mixed) hyperlipidemia (type IIa & IIb hyperlipoproteinemia), hypertriglyceridemia (type IV) & dysbetalipoproteinemia (type III). Adjunctive therapy in patients w/ homozygous familial hypercholesterolemia who have LDL-receptor function.